IP Library › Granted Patent US 11,156,603
Granted Patent B2
US 11,156,603 · App. 17/321,090 · Granted Oct 26, 2021

Spatially encoded biological assays

Inventor: Mark S. Chee (San Diego, CA)
Assignee: Prognosys Biosciences, Inc.
G01N33/543B01L3/502715C12Q1/6804C12Q1/6809C12Q1/6834C12Q1/6837C12Q1/6841C12Q1/6869C12Q1/6874C40B30/04C40B60/04G01N33/5308G01N33/6845G01N2458/10
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,156,603
App. No.
17/321,090
Filed
May 14, 2021
Granted
Oct 26, 2021
Kind
B2
Art Unit
1634
USPC
506/16
Abstract

Provided herein are methods of identifying a target protein in a tissue sample that include delivering a plurality of probes to a tissue sample, where a probe of the plurality of probes comprises an antibody conjugated to an oligonucleotide having a sequence, where the antibody specifically binds to the target protein in the tissue sample; amplifying the oligonucleotide to generate an amplicon comprising copies of the oligonucleotide; detecting all or a portion of a copy of the oligonucleotide in the amplicon; and using the detected sequence to identify the target protein in the tissue sample.

Claims (22)

1. A method of identifying a target protein in a tissue sample comprising:

(a) delivering a plurality of probes to a tissue sample, wherein a probe of the plurality of probes comprises an antibody conjugated to an oligonucleotide having a sequence, and wherein the antibody specifically binds the target protein in the tissue sample;

(b) amplifying the oligonucleotide to generate an amplicon comprising copies of the oligonucleotide;

(c) detecting all or a portion of a copy of the oligonucleotide in the amplicon by:

(i) hybridizing a probe comprising a sequence that is 100% complementary to a portion of the sequence of the oligonucleotide and a label, to a copy of the oligonucleotide in the amplicon; and

(ii) imaging the tissue sample after (i) to detect the label in the tissue sample; and

(d) using the detected sequence to identify the target protein in the tissue sample.

2. The method of claim 1 , wherein the method further comprises separating one or more probes of the plurality of probes that are not bound to the target protein from the tissue sample.

3. The method of claim 2 , wherein the separating comprises washing the tissue sample to separate the probes that are not bound to the target protein from the tissue sample.

4. The method of claim 1 , wherein the label comprises a fluorophore.

5. The method of claim 1 , wherein the method further comprises identifying a region of interest in the tissue sample.

6. The method of claim 1 , wherein the method further comprises associating the image of the tissue sample with the detected sequence, thereby identifying one or more target protein locations in the tissue sample.

7. The method of claim 1 , wherein the method further comprises associating a location of the label in the image of the tissue sample with the detected sequence, thereby identifying a location of the target protein in the tissue sample.

8. The method of claim 1 , wherein the tissue sample comprises a tissue section.

9. The method of claim 1 , wherein the tissue sample comprises a formalin-fixed paraffin embedded tissue sample.

10. The method of claim 1 , wherein the tissue sample comprises fresh-frozen tissue sample.

11. The method of claim 1 , wherein the method further comprises determining an abundance of the target protein in the tissue sample.

12. The method of claim 11 , wherein the plurality of probes comprises multiple probes that bind to the target protein in the tissue sample, and wherein determining the abundance of the target protein comprises:

hybridizing probes each comprising a sequence that is 100% complementary to a portion of the sequence of the oligonucleotide, and the label, to copies of the oligonucleotide in the amplicon;

imaging the tissue sample after hybridizing the probes to detect the labels of the hybridized probes, and

quantifying an amount of the hybridized probes in the tissue sample based on the detected labels to determine the abundance of the target protein.

13. The method of claim 1 , wherein four or more probes of the plurality of probes specifically bind to different target proteins in the tissue sample.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 18, 2021
From: CHEE, MARK S.
To: PROGNOSYS BIOSCIENCES, INC.
Reel/Frame 056270/0237 →
Continuity (11)
Continuation 17145210 · Jan 8, 2021
Continuation 16669246 · Oct 30, 2019
Continuation 16437637 · Jun 11, 2019
Continuation 16430015 · Jun 3, 2019
Continuation 16414213 · May 16, 2019
Continuation 16402098 · May 2, 2019
Continuation 16276235 · Feb 14, 2019
Continuation 15187661 · Jun 20, 2016
Continuation 13080616 · Apr 5, 2011
Provisional Application 61321124 · Apr 5, 2010
Related Publication 20210270822A1 · Sep 2, 2021
Cited By (44)
US 12,195,790 US 12,203,134 US 12,209,280 US 12,223,751 US 12,228,544 US 12,241,060 US 12,241,890 US 12,249,085 US 12,265,079 US 12,270,077 US 12,275,988 US 12,281,357 US 12,286,673 US 12,287,264 US 12,297,486 US 12,344,892 US 12,365,935 US 12,365,942 US 12,371,688 US 12,378,607 US 12,385,083 US 12,399,123 US 12,404,544 US 12,405,264 US 12,416,603 US 12,435,363 US 12,442,045 US 12,497,654 US 12,508,590 US 12,529,094 US 12,545,949 US 12,553,805 US 12,553,898 US 12,566,113 US 12,566,114 US 12,571,029 US 12,624,475 US 12,637,706 US 12,668,835 US 12,692,492 US 12,730,295 US 12,735,743 US 12,742,166 US 12,742,199